No two strokes are alike - the damage from each stroke leaves its own unique signature on a person's brain and behaviour. The current project will investigate how different types of stroke affect a person's long term recovery or deterioration
Raconteur is a publishing house and agency which produces special reports and commentary for the Times and Sunday Times.
Published on Saturday 9 May 2015, the 'Understanding Stroke 2015' report consists of a number articles covering different areas of current stroke news.
The European Stroke Organisation Conference (ESOC) 2018 is currently on from 16-18 May in Gothenburg, Sweden. The first day of ESOC included some truly inspiring scientific sessions, including the WAKE-UP trial, RIGHT-2 trial and CROMIS-2 trials.
About 80% of strokes are caused by a blocked blood vessel. One third of these patients have a blockage of a large blood vessel in the neck or brain known as large artery occlusion stroke (LAOS).
Our report ‘Current, future and avoidable costs of stroke in the UK’ suggests that investing in stroke research today could lead to a significant reduction in the burden of stroke in the future.
We need your support to continue to invest in research that will help to save lives and enable stroke survivors to make the best possible recovery.
Thrombolysis, where drugs are injected into the blood to break up a blood clot, is one of the main treatments used to treat people who are having a stroke caused by a clot. Currently a drug called alteplase is used in thrombolysis. But the researchers think that another drug, called tenecteplase, may be more effective than alteplase. This study will investigate if this is the case.
We anticipate a shortfall of £1.5 million in our funding programme this year to resume current research and support vital new projects. This could have a catastrophic knock-on effect for stroke research and delay access to important new life-changing treatments that allow people to rebuild their lives after stroke.
The Stroke Association is also a member of the Stroke Alliance for Europe (SAFE), a network of organisations that champion the voices of those affected by stroke. SAFE is currently involved in several European research projects. You can find out more about these projects hoping to improve treatment for stroke patients.
Vascular dementia is the 2nd leading cause of dementia in the UK and there are currently no proven treatments. A new study at the University of Southampton is now investigating whether a failure of fluid drainage along the walls of blood vessels in the brain is a cause of vascular dementia.